Silencing ARC reduced primary tumor burden. ARC knockdown also repressed the invasion of BC cells, reduced the number of circulating cancer cells and lung metastases. ARC overexpression had the opposite effects. In addition, endogenous ARC enhanced drug resistance in primary tumors and invading cells. Here, ARC is linked to breast cancer.